July 5th, 2024 – As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce a new ethylene oxide (EO) processing facility in Singapore through a strategic partnership with TOMOE SHOKAI CO., Ltd (“TOMOE”).
Details
June 24, 2024 – As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce the completed expansion of its existing Libertyville II, Illinois gamma processing facility to include X-ray processing.
Details
April 8, 2024 – As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce the expansion of its existing Suzhou, China EO processing facility to include X-ray processing.
Details
April 2, 2024 – As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce the completed expansion of its existing Chonburi I, Thailand facility to include X-ray processing.
Details
November 2023 – STERIS is pleased to announce that its Applied Sterilization Technologies (AST) business has been accepted to participate in the U.S. Food and Drug Administration (FDA) Radiation Sterilization Master File Pilot Program (Pilot Program).
Details
September 2023 – One Team One Goal (OTOG) is at the core of our organization and reflects our collective values. OTOG is the vehicle we use to drive our culture across the global network of employees and facilities.
Details